Company
Agios Pharmaceuticals
NASDAQ:AGIO
Agios is passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism.
5 stories
PRE-MARKET MOVERS: Salmonella food scare continues and Alphabet shares surge after earnings
Also in the frame in pre-market was Agios Pharmaceuticals Inc after an FDA approval and Campbell Soup Company
PRE-MARKET MOVERS: Salmonella food scare continues and Alphabet shares surge after earnings; Quest Diagnostics Inc results fail to cheer
Also in the frame in pre-market was Agios Pharmaceuticals Inc after an FDA approval and Campbell Soup Company
PRE-MARKET MOVERS: Salmonella food scare continues and Alphabet shares surge after earnings; Quest Diagnostics Inc results fail to cheer
Also in the frame in pre-market was Agios Pharmaceuticals Inc after an FDA approval and Campbell Soup Company
Agios says adios to some investors as cash seen shrinking
Shares of Agios Pharmaceuticals lose 13% after the company reports disappointing full-year results and a sapped cash outlook